Clinical Trials Logo

Filter by:
NCT ID: NCT04576169 Recruiting - Clinical trials for Triangular Fibrocartilage Complex Injury

Trial Comparing Treatment Strategies in Triangular Fibrocartilage Complex Ruptures

REINFORCER
Start date: October 27, 2020
Phase: N/A
Study type: Interventional

Trial is a prospective, randomized, controlled, outcome assessor and participant (in other randomization cohort of the trial) blinded, two randomization cohorts, which each has two parallel 1:1 arms, a multinational and -centre trial comparing the efficacy of 1) debridement with placebo surgery and 2) repair with physiotherapy. The primary objective is to compare efficacy of surgery, depending on the type of injury, with either placebo surgery or physiotherapy in 1-year follow-up in two randomization cohorts.

NCT ID: NCT04576156 Recruiting - Myelofibrosis Clinical Trials

A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment

Start date: April 12, 2021
Phase: Phase 3
Study type: Interventional

The purpose of the study is to evaluate the overall survival of participants treated with imetelstat compared to best available therapy with intermediate-2 or high-risk Myelofibrosis (MF) who are relapsed/refractory to Janus Kinase (JAK)-Inhibitor treatment.

NCT ID: NCT04576130 Recruiting - Clinical trials for Coronary Artery Disease

A Danish ICD-study in Patients With Coronary Artery Disease Resuscitated From Ventricular Fibrillation

DanICD
Start date: October 12, 2020
Phase: N/A
Study type: Interventional

DanICD is a randomized, controlled study to with the aim to assess whether there is a benefit of ICD-implantation in patients with coronary artery disease (including acute myocardial infarction), who survive cardiac arrest due to ventricular fibrillation/sustained ventricular tachycardia and undergo revascularization and with an LVEF above 35%.

NCT ID: NCT04575103 Recruiting - Arrythmia Clinical Trials

Monitoring of Arrhythmias in Patients Treated With Antipsychotics

MAPP
Start date: January 1, 2021
Phase: N/A
Study type: Interventional

Antipsychotics may be associated to life-threatening arrhythmias and sudden cardiac death. This is the fist study to estimated the arrhythmic burden using long-term monitoring by implantable loop recorder in patients treated with antipsychotics.

NCT ID: NCT04574336 Recruiting - Clinical trials for Fracture Humerus of Shaft

Scandinavian Humeral Diaphyseal Fracture Trial

SHAFT
Start date: April 4, 2022
Phase: N/A
Study type: Interventional

This pragmatic multicenter randomized controlled trial (RCT) includes adult participants with an acute humeral shaft fracture to compare surgical fixation of humeral shaft fracture to non-surgical treatment with early identification and treatment of delayed union by a patient-reported outcome after 52 weeks. The trial population of 287 participants The trial population is divided in two age-groups due to the changes in DASH score by age. The definition of delayed union differs in the young and elderly population to consider dissimilarity in bone healing rates and the timepoint for crossover is therefor different between the groups. Participants will be randomized 1:1 between non-surgical treatment and surgical treatment. The primary outcome is the Disability of Arm, Shoulder and Hand (DASH) score at 52 weeks, and is assessor blinded. The secondary outcomes are DASH score earlier than 52 weeks, EQ-5D-5L, pain assessed by visual analogue score, Constant-Murley score including elbow range of motion and anchor-questions collected at all timepoints throughout the trial. All complications will be reported including; infection, nerve or vascular injury, surgical revisions (implant malpositioning, hardware failure, aseptic loosening and peri-implant fracture), major adverse cardiovascular events, other major adverse events and mortality. SHAFT will provide information on the effectiveness of two standard treatments for humeral shaft fractures, while taking the dilemmas within the population into account.

NCT ID: NCT04572139 Recruiting - Aging Clinical Trials

Age-related Differences in Response to Pituitary Stimulation Tests

Start date: September 23, 2020
Phase:
Study type: Observational

The purpose of this study to age-related differences to the response of a combined pituitary stimulation test with TRH, LHRH and ACTH.

NCT ID: NCT04571840 Recruiting - Prostate Cancer Clinical Trials

Prostate Imaging Using MRI +/- Contrast Enhancement

PRIME
Start date: April 5, 2022
Phase: N/A
Study type: Interventional

This prospective clinical trial (PRostate Imaging using Mri +/- contrast Enhancement (PRIME)) aims to assess whether biparametric MRI (bpMRI) is non-inferior to multiparametric mpMRI (mpMRI) in the detection of clinically significant prostate cancer. This means that we are comparing MRI scans that requires injection of IV contrast (the current standard practice) versus MRI scans that can be performed without IV contrast in the detection of prostate cancer.

NCT ID: NCT04570683 Recruiting - Immunotherapy Clinical Trials

Laser Immunotherapy With and Without Topical Anti-PD1 in Basal Cell Carcinomas

Start date: January 27, 2020
Phase: Early Phase 1
Study type: Interventional

The study aim is to assess the immunological and clinical response in basal cell carcinoma (BCC) treated with ablative fractionated laser (AFL) as monotherapy and compare with BCC treated with combination-therapy of AFL and the anti-PD1-drug nivolumab and with nivolumab as monotherapy.

NCT ID: NCT04567056 Recruiting - Clinical trials for Head and Neck Squamous Cell Carcinoma

Specific Methylation Profiles in HNSCC

Start date: September 16, 2020
Phase:
Study type: Observational

In the study, N-20190047, the investigators aim to define specific methylation patterns in a group of patients with head and neck squamous cell carcinomas. With this study the investigators aim to validate these findings in a larger cohort.

NCT ID: NCT04564430 Recruiting - Trigger Finger Clinical Trials

Clonidine for Tourniquet-related Pain in Children

CLOTCH
Start date: March 1, 2021
Phase: Phase 4
Study type: Interventional

This study is designed as a randomized, placebo-controlled, double-blinded, clinical trial with two parallel groups. This study investigates the association between a single dose of the drug, Clonidine, and the total amount of opioid administered under and 24 hours after surgery in children undergoing orthopedic limb surgery with the use of tourniquet. The investigators hypothesize that administration of clonidine to children undergoing limb surgery with the use of inflatable tourniquets would reduce post-procedural pain. This study is a pilot to obtain an effect size. Based on this the investigators will calculate a sample size for the main trial enabling us to reach a power of 0.8 with a significans level of 0.05.